Pulmonary Fibrosis

HomePatientsLung Disease Week at the ATS2013Pulmonary Fibrosis ▶ Information for Experts
Information for Experts

Pulmonary Fibrosis Week

Clinician
ATS Educational Products

2013

A85 METHODS TO STUDY LUNG INJURY AND REPAIR
A91 THERAPEUTIC STRATEGIES IN IDIOPATHIC PULMONARY FIBROSIS: DEBATES BETWEEN BENCH AND BEDSIDE: A PRO-CON DEBATE
D2 ADDING INSULT TO INJURY: COMPLICATIONS OF IDIOPATHIC PULMONARY FIBROSIS

2012

A111 DRUGS, REGULATORY AGENCIES AND GUIDELINES: THE CHALLENGE OF IDIOPATHIC PULMONARY FIBROSIS
B5 IDIOPATHIC INTERSTITIAL PNEUMONIAS/PULMONARY FIBROSIS: IS 'IDIOPATHIC' TRULY 'IDIOPATHIC'?
PG17 MANAGEMENT OF INTERSTITIAL LUNG DISEASE: A CASE-BASED APPROACH

Clinician
ATS Journal articles on Pulmonary Fibrosis

Pulmonary Fibrosis: AJRCCM

Idiopathic Pulmonary Fibrosis: Lung Function is a Clinically Meaningful Endpoint for Phase III Trials
Read Abstract
Vol. 186, No. 8, Oct. 2012 

Gastroesophageal Reflux Therapy is Associated with Longer Survival in Patients with Idiopathic Fibrosis                                            
Read Abstract                                    
Volume 184, No. 12, Dec. 2011

Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis
Read Abstract                                             
Vol. 183, No. 4, Feb. 2011

Acute Exacerbations of Idiopathic Pulmonary Fibrosis
Read Abstract                                                                            
Vol. 176, No. 1, October 2007

Mortality from Pulmonary Fibrosis Increased in the United States from 1992 – 2003 Read Abstract                                              
Vol. 176, No. 3, August 2007

To Clot or Not, That is the Question in Pulmonary Fibrosis
Read Abstract                                                        
Vol. 167, No. 12, June 2003

Approaches to the Treatment of Pulmonary Fibrosis
Read Abstract                                           
Vol. 151, No. 3, March 1995 

Pulmonary Fibrosis: AJRCMB

Telomerase and Telomerase Length in Pulmonary Fibrosis
Read Abstract
Volume 49, No. 2, August 2013

Periostin, a Matricellular Protein, Plays a Role in the Induction of Chemokines in Pulmonary Fibrosis                                         
Read Abstract                                         
Volume 46, Issue 5, May 2012 

Endothelial-Mesenchymal Transition in Bleomycin-Induced Pulmonary Fibrosis
Read Abstract                                        
Volume 43, Issue 2, Aug. 2010

Potential Role of Endothelin-1 in Pulmonary Fibrosis: From the Bench to the Clinic Read Abstract                                               
Vol. 42, No. 1, Jan. 2010

Pulmonary Fibrosis: Searching for Model Answers
Read Abstract                                                               
Vol. 33, No. 1, July 2005

A Matrix for New Ideas in Pulmonary Fibrosis
Read Abstract                                                         
Vol. 27, No. 2, Aug. 2002 

Pulmonary Fibrosis: PATS/Annals

The Genetic and Environmental Causes of Pulmonary Fibrosis
Read Abstract                                             
PATS Vol. 9, No. 3, July 2012 

Stem Cells and Pulmonary Fibrosis: Cause or Cure?
Read Abstract                                             
PATS Vol. 9, No. 3, July 2012

Proteasomal Regulation of Pulmonary Fibrosis
Read Abstract                                               
PATS Vol. 7, No. 1, Feb. 2010

State of the Art. Does Current Knowledge Explain the Pathogenesis of Idiopathic Pulmonary Fibrosis? A perspective                  
Read Abstract                                                
Vol. 4, No. 5, August 2007

Is Idiopathic Pulmonary Fibrosis an Environmental Disease?
Read Abstract                                                
Vol. 3, No. 4, June 2006 

Current Perspectives on the Treatment of Idiopathic Pulmonary Fibrosis
Read Abstract                                            
PATS Vol. 3, No. 4, June 2006


Clinician
ATS Statements, Guidelines and Reports

ATS Statements, Guidelines and Reports are printed in the American Journal of Respiratory and Critical Care Medicine. These documents are also available in PDF format. You may download one copy of any ATS document; there is no charge for this service. Some examples below: